Non motor subtypes and Parkinson's disease

Parkinsonism and Related Disorders

Volumn 22, Issue , 2016, Pages S41-S46

  Sauerbier, Anna ^a,b   Jenner, Peter ^a   Todorova, Antoniya ^a,b   Chaudhuri, K Ray ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Non motor symptoms; Parkinson's disease; Subtyping

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL HISTORY; NEUROPATHOLOGY; NON MOTOR SYMPTOM; PARK ANXIETY; PARK APATHY; PARK AUTONOMIC; PARK COGNITIVE SUBTYPE; PARK DEPRESSION; PARK FATIGUE; PARK PAIN; PARK SLEEP; PARKINSON DISEASE; PRIORITY JOURNAL; SYMPTOM; ANIMAL; BRAIN STEM; CLASSIFICATION; COGNITION DISORDERS; MOTOR SKILLS DISORDERS; OLFACTORY SYSTEM; PATHOLOGY; PHENOTYPE; SLEEP WAKE DISORDERS;

ANIMALS; BRAIN STEM; COGNITION DISORDERS; HUMANS; MOTOR SKILLS DISORDERS; OLFACTORY PATHWAYS; PARKINSON DISEASE; PHENOTYPE; SLEEP WAKE DISORDERS;

EID: 84947863914     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.09.027     Document Type: Article

References (33)

1. Chaudhuri K.R., Healy D., Schapira A.H.V. The non motor symptoms of PD disease. Diagnosis and management. Lancet Neurol. 2006, 5:235-245.
2. Berg D., Postuma R.B., Bloem B., et al. Time to Redefine PD? Introductory statement of the MDS task force on the definition of Parkinson's disease. Mov. Disord. 2014, 29:454-462.
3. Todorova A., Jenner P., Chaudhuri K.Ray Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected. Pract. Neurol. 2014, 14:310-322.
4. Martinez-Martin P., Rodriguez-Blazquez C., Kurtis M.M. The impact of non motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov. Disord. 2011, 26:399-406.
5. Jellinger K.A. Neuropathology of sporadic PD disease: evaluation and change of concepts. Mov. Disord. 2012, 27:8-30.
6. Kingsbury A.E., Bandopadhay R., Silveira-Moriyama L., et al. Brain stem pathology in PD disease: an evaluation of the Braak staging model. Mov. Disord. 2010, 25:2508-2515.
7. Halliday G., Lees A., Stern M. Milestones in Parkinson's disease-clinical and pathological features. Mov. Disord. 2011, 26:1015-1021.
8. Del Tredici K., Rub U., De Vos R.A., Bohl J.R., Braak H. Where does Parkinson disease pathology begin in the brain?. J. Neuropathol. Exp. Neurol. 2002, 61:413-426.
9. Beach T.G., Adler C.H., Lue L., et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol. 2009, 117:613-634.
10. Gai W.P., Halliday G.M., Blumbergs P.C., Geffen L.B., Blessing W.W. Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson's disease. Brain 1991, 114:2253-2267.
11. Braak H., Del Tredici K., Rüb U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic PD disease. Neurobiol. Aging 2003, 24:197-211.
12. Erro R., Vitale C., Amboni M., et al. The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. PLoS One 2013, 8:e70244.
13. Pont-Sunyer C., Hotter A., Gaig C., et al. The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study). Mov. Disord. 2015, 30:229-237.
14. Zis P., Erro R., Walton C.C., Sauerbier A., Chaudhuri K.Ray The range and nature of non-motor symptoms in drug-naive Parkinson's disease patients: a state-of-the-art systematic review. Nat. Parkinson's J. (NPJ) Parkinson's Dis. 2015, 15013.
15. Todorova A., Martinez-Martin P., Schrag A., Rizos A., Weintraub D., Chaudhuriand K.Ray, on behalf of EUROPAR and the IPMDS Non Motor PD Non-motor dominant profiles in Parkinson's disease: first analysis from an international naturalistic study. Mov. Disord. 2014, 29:1068. [abstract].
16. Zarei M., Ibarretxe-Bilbao N., Compta Y., et al. Cortical thinning is associated with disease stages and dementia in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2013, 84:875-882.
17. Williams-Gray C.H., Evans J.R., Goris A., et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009, 132:2958-2969.
18. Goris A., Williams-Gray C.H., Clark G.R., et al. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. Ann. Neurol. 2007, 62:145-153.
19. Dujardin K., Langlois C., Plomhause L., et al. Apathy in untreated early-stage Parkinson disease: relationship with other non-motor symptoms. Mov. Disord. 2014, 29:1796-1801.
20. Brown R.G., Landau S., Burn D.J., et al. Depression and anxiety-related subtypes in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2011, 82:803-809.
21. Burn D.J., Landau S., Hindle J.V., et al. Parkinson's disease motor subtypes and mood. Mov. Disord. 2012, 27:379-386.
22. Remy P., Doder M., Lees A., et al. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005, 128. 1314-22SR.
23. Romenets J.F., Gagnon V., Latreille M., et al. Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease. Mov. Disord. 2012, 27:996-1003.
24. Scherfler C., Frauscher B., Schocke M., et al. White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann. Neurol. 2011, 69:400-407.
25. Pavese N., Metta V., Simpson B.S., et al. Sleep regulatory centres dysfunction in Parkinson's disease patients with excessive daytime sleepiness. An in vivo study. Park Relat. Disord. 2012, 18:S24-S25.
26. Schifitto G., Friedman J.H., Oakes D., et al. Fatigue in levodopa-naive subjects with Parkinson disease. Neurology 2008, 71:481-485.
27. Pavese N., Metta V., Bose S.K., Chaudhuri K.R., Brooks D.J. Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. Brain 2010, 133:3434-3443.
28. Quinn N.P., Lang A.E., Koller W.C., Marsden C.D. Painful Parkinson's disease. Lancet 1986, 1:1366-1369.
29. Wallace V.C., Chaudhuri K.R. Unexplained lower limb pain in Parkinson's disease: a phenotypic variant of "painful Parkinson's disease". Park. Relat. Disord. 2014, 20:122-124.
30. Espay A.J., LeWitt P.A., Kaufmann H. Norepinephrine deficiency in Parkinson's disease: the case for noradrenergic enhancement. Mov. Disord. 2014, 29:1710-1719.
31. Sharma J.C., Turton J. Olfaction, dyskinesia and profile of weight change in Parkinson's disease: identifying neurodegenerative phenotypes. Parkinsonism Relat. Disord. 2012, 18:964-970.
32. Breen K., Drutyte G. Non motor symptoms of PD disease: the patients perspective. J. Neural. Transm. 2013, 120:531-535.
33. Yoritaka A., Ohizumi H., Tanaka S., Hattori N. Parkinson's disease with and without REM sleep behaviour disorder: are there any clinical differences?. Eur. Neurol. 2009, 61:164-170.